The Charity CEO Podcast Ep 25. Michelle Mitchell OBE, CEO Cancer Research UK: Cancer care, COVID-19 and the power of collaboration
Nov 8, 2021
49:00
“Leaders who can convene and collaborate are going to be best placed to navigate the challenges of the post-pandemic world… No one (single) person, no one organisation, in fact no one country can beat cancer... we go faster when we collaborate and partner.”
Michelle Mitchell epitomises her organisation’s strap-line: Together we will beat cancer.
Driven by an absolute determination to accelerate progress in cancer research, Michelle shares leadership insights and lessons learned from being CEO of this £600m organisation.
Being the world’s largest independent funder of cancer research, has not meant that Cancer Research UK has been immune to the effects of the pandemic. CRUK is predicting a £250m drop in income over the next 3 years, which will seriously impact their ambitions to enable 3 in 4 people to survive cancer by 2034.
We also talk about the impact the disruption of the past 18 months has had on the cancer community; and the importance of partnership, and the One Cancer Voice collaboration, in ensuring the continued delivery of world-class cancer services.
Recorded September 2021.
Guest Biography
Michelle Mitchell OBE is Cancer Research UK’s first female CEO. CRUK is the world's largest independent funder of cancer research. Michelle believes that by working together, and building the strongest possible team, we will beat cancer together. She is a member of the National Cancer Board, and has extensive non-executive experience, serving on the Boards of NHS England and The King’s Fund, a leading health policy think-tank. Before joining Cancer Research UK, Michelle was CEO of the MS Society for five years. Prior to that, she was Director General at Age UK, the UK’s largest older people’s charity. Michelle has a BA in Economics, an MA in Politics and Public Administration and an International Executive Diploma from INSEAD. Michelle was awarded an OBE in 2015 for services to the charity sector.
Links
https://www.cancerresearchuk.org/
This episode is sponsored by EdenTree Investment Management
https://www.edentreeim.com/
Michelle Mitchell epitomises her organisation’s strap-line: Together we will beat cancer.
Driven by an absolute determination to accelerate progress in cancer research, Michelle shares leadership insights and lessons learned from being CEO of this £600m organisation.
Being the world’s largest independent funder of cancer research, has not meant that Cancer Research UK has been immune to the effects of the pandemic. CRUK is predicting a £250m drop in income over the next 3 years, which will seriously impact their ambitions to enable 3 in 4 people to survive cancer by 2034.
We also talk about the impact the disruption of the past 18 months has had on the cancer community; and the importance of partnership, and the One Cancer Voice collaboration, in ensuring the continued delivery of world-class cancer services.
Recorded September 2021.
Guest Biography
Michelle Mitchell OBE is Cancer Research UK’s first female CEO. CRUK is the world's largest independent funder of cancer research. Michelle believes that by working together, and building the strongest possible team, we will beat cancer together. She is a member of the National Cancer Board, and has extensive non-executive experience, serving on the Boards of NHS England and The King’s Fund, a leading health policy think-tank. Before joining Cancer Research UK, Michelle was CEO of the MS Society for five years. Prior to that, she was Director General at Age UK, the UK’s largest older people’s charity. Michelle has a BA in Economics, an MA in Politics and Public Administration and an International Executive Diploma from INSEAD. Michelle was awarded an OBE in 2015 for services to the charity sector.
Links
https://www.cancerresearchuk.org/
This episode is sponsored by EdenTree Investment Management
https://www.edentreeim.com/